OOIR: Observatory of International Research

Papers

(The TQCC of Seminars in Immunology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Learning from Inborn Errors of Immunity: From mechanisms to translation	121
Myeloid derived suppressor cells in tumor microenvironment: Interaction with innate lymphoid cells	93
Editorial Board	92
Durability of immune responses to SARS-CoV-2 infection and vaccination	80
Editorial Board	70
Resolution pharmacology − A fresh approach to the clinical management of human inflammatory diseases	69
Microbial gasdermins: More than a billion years of pyroptotic-like cell death	66
Toolkit for mapping the clonal landscape of tumor-infiltrating B cells	60
Thymus aging and immune reconstitution, progresses and challenges	50
Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities	50
Annexin A1 based inflammation resolving mediators and nanomedicines for inflammatory bowel disease therapy	49
Exploiting antifungal immunity in the clinical context	49
Baseline immune states (BIS) associated with vaccine responsiveness and factors that shape the BIS	47
Recent developments in C3-targeted complement therapeutics	46
The origins, manifestations, and potential treatments of allergic disorders	45
Sialic acid and Siglec receptors in tumor immunity and immunotherapy	37
Versatile neutrophil functions in cancer	37
T cell immunity to SARS-CoV-2	36
Harnessing the power of oncolytic virotherapy and tertiary lymphoid structures to amplify antitumor immune responses in cancer patients	36
B cells and the intestinal microbiome in time, space and place	35
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel	35
Systems biology of B cells in COVID-19	35
The role of unconventional T cells in maintaining tissue homeostasis	34
Formyl peptide receptor 2 and heart disease	34
High-throughput N-glycan analysis in aging and inflammaging: State of the art and future directions	33

Future indications and clinical management for fecal microbiota transplantation (FMT) in immuno-oncology	33
Antigen discovery for the development of cancer immunotherapy	32
The role of ILC subsets in cancer	32
Connecting the dots: Neutrophils at the interface of tissue regeneration and cancer	31
Discovering C3 targeting therapies for paroxysmal nocturnal hemoglobinuria: Achievements and pitfalls	30
Systems analysis of innate and adaptive immunity in Long COVID	29
Immune aging – A mechanism in autoimmune disease	29
Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair	29
Development of synthetic lipoxin-A4 mimetics (sLXms): New avenues in the treatment of cardio-metabolic diseases	28
Immune responses to SARS-CoV-2 infection and vaccination in children	27
Immunomodulatory effects of G-CSF in cancer: Therapeutic implications	27
G-CSF, the guardian of granulopoiesis	27
DNGR-1-mediated cross-presentation of dead cell-associated antigens	27
Nanoparticles for generating antigen-specific T cells for immunotherapy	26
Genetics of Inborn Errors of Immunity in highly consanguineous Middle Eastern and North African populations	26
IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC	25
Accumulation of immune-suppressive CD4 + T cells in aging – tempering inflammaging at the expense of immunity	24
Decoding the multifaceted roles of galectins in self-defense	23
Pyroptosis-induced inflammation and tissue damage	23
The dual role of neutrophils in cancer	23
Cellular and Molecular Diversity in Scleroderma	23
They shall not grow mold: Soldiers of innate and adaptive immunity to fungi	21
Neurogenic inflammation and itch in barrier tissues	21
The impact of immunopeptidomics: From basic research to clinical implementation	21
Correcting inborn errors of immunity: From viral mediated gene addition to gene editing	20
The gut mucus network: A dynamic liaison between microbes and the immune system	19
NGS data analysis for molecular diagnosis of Inborn Errors of Immunity	19
Immunomodulatory and immunoregulatory nanomedicines for autoimmunity	18
Integrating immunopeptidome analysis for the design and development of cancer vaccines	18
Editorial Board	18
Introduction to the Special Issue: Nutrition, microbiota and immunity	17
Introduction to the special issue: Cellular and molecular diversity in rheumatic autoimmune diseases	17
Application of the C3 inhibitor compstatin in a human whole blood model designed for complement research – 20 years of experience and future perspectives	17
Microbial metabolites and immunotherapy: Basic rationale and clinical indications	16
The immunology and cell biology of T cell aging	16
Inflammasomes as regulators of non-infectious disease	16
Introduction to the Special Issue: The Immunopeptidome	16
Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming	16
Pyroptosis modulation by bacterial effector proteins	16